Strategic Blueprint’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Strategic Blueprint's EXAS Position: Q2 2025 in Review
Strategic Blueprint sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 4,833 shares — an estimated $209K sold.
Strategic Blueprint first reported a position in EXAS in Q3 2019 and held it in 21 quarters. The position peaked at $564K in Q2 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.
- Strategic Blueprint reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
- Strategic Blueprint sold 4,833 Exact Sciences shares in Q2 2025, an estimated $209K.
- Strategic Blueprint first reported a position in Exact Sciences in Q3 2019 and held it in 21 quarters.
- Strategic Blueprint's Exact Sciences position peaked at $564K in Q2 2021.
- 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.
Based on Strategic Blueprint's 13F filing for Q2 2025, filed 30 Jul 2025.